A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis; BREEZE-AD5

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleA Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis; BREEZE-AD5
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsJohn C Browning